.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
McKinsey
Deloitte
Mallinckrodt
US Department of Justice
UBS
Medtronic
Teva
Federal Trade Commission

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208573

« Back to Dashboard
NDA 208573 describes VENCLEXTA, which is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the VENCLEXTA profile page.

The generic ingredient in VENCLEXTA is venetoclax. One supplier is listed for this compound. Additional details are available on the venetoclax profile page.

Summary for 208573

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:2

Pharmacology for NDA: 208573

Mechanism of ActionP-Glycoprotein Inhibitors
Physiological EffectIncreased Cellular Death

Suppliers and Packaging for NDA: 208573

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VENCLEXTA
venetoclax
TABLET;ORAL 208573 NDA AbbVie Inc. 0074-0561 0074-0561-11 1 BLISTER PACK in 1 CARTON (0074-0561-11) > 2 TABLET, FILM COATED in 1 BLISTER PACK
VENCLEXTA
venetoclax
TABLET;ORAL 208573 NDA AbbVie Inc. 0074-0561 0074-0561-14 1 BLISTER PACK in 1 CARTON (0074-0561-14) > 14 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Apr 11, 2016TE:RLD:Yes
Regulatory Exclusivity Expiration:Apr 11, 2021
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Apr 11, 2023
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:► SubscribePatent Expiration:Jun 27, 2031Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Citi
Cerilliant
Covington
McKinsey
Julphar
US Army
Cipla
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot